Vascular Endothelial Growth Factor (VEGF) and Its Role in the Cardiovascular System

Area of Science:

• Cardiovascular Research
• Molecular Biology
• Angiogenesis

Background:

• Cardiovascular diseases (CVDs) are the leading global cause of death, with ischemic heart disease (IHD) being most prevalent.
• Vascular endothelial growth factor (VEGF) is critical for ischemia-induced angiogenesis, a process vital for heart health.
• Understanding VEGF's role in cardiac physiology and pathology is essential for advancing CVD research.

Purpose of the Study:

• To explore the multifaceted role of VEGF in cardiovascular diseases.
• To review the therapeutic potential and challenges of VEGF-based therapies.
• To examine VEGF as a biomarker for collateral circulation and heart failure mortality.

Main Methods:

• Literature review of preclinical and clinical studies on VEGF in cardiovascular diseases.
• Analysis of VEGF's involvement in angiogenesis and its implications for IHD.
• Evaluation of current research on VEGF-targeted therapies and their cardiovascular side effects.

Main Results:

• VEGF plays a crucial role in angiogenesis following cardiac ischemia.
• VEGF-based therapies show promise in preclinical models but require further clinical validation.
• VEGF is a potential biomarker for assessing collateral circulation and predicting heart failure mortality.

Conclusions:

• VEGF is a significant factor in cardiovascular pathophysiology and a potential therapeutic target.
• Further research is needed to clarify the clinical efficacy and safety of VEGF-targeted therapies.
• VEGF's role as a biomarker warrants continued investigation for improved patient outcomes in heart disease.